Hypotensive activity of thymoquinone in normotensive rats and its receptor mechanisms
Objective: The objectives of the current study were to confirm the blood pressure lowering effect of thymoquinone (TQ) and to investigate its mechanism through muscarinic and β-adrenergic receptors. Methods: Mean arterial blood pressure (MAP) was recorded using the non-invasive blood pressure tail...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://eprints.unisza.edu.my/5367/1/FH02-FP-17-10642.pdf http://eprints.unisza.edu.my/5367/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Sultan Zainal Abidin |
Language: | English |
Summary: | Objective: The objectives of the current study were to confirm the blood pressure lowering effect of thymoquinone (TQ) and to investigate its
mechanism through muscarinic and β-adrenergic receptors.
Methods: Mean arterial blood pressure (MAP) was recorded using the non-invasive blood pressure tail-cuff technique. A dose-response relationship
was obtained after using 3 TQ doses (2.5, 5 and 10 mg/kg) intraperitoneally to 3 different groups (n =5) of adult rats under pentobarbital anesthesia.
MAP was then measured for another 2 animal groups pretreated either with atropine (P-at) or propranolol (P-pro) followed by 10 mg/kg TQ.
Results: TQ produced a significant dose-dependent blood pressure and heart rate lowering effect. TQ-induced MAP reduction was significantly less
pronounced in P-at (12±2.8 mmHg) than non-pretreated group (29±3.2 mmHg) with P<0.01. Conversely, TQ-induced MAP reduction in P-pro
(28±3.4 mmHg) did not demonstrate a significant difference from the non-pretreated group (29±3.2 mmHg) with P>0.05.
Conclusion: This study confirms the dose-related hypotensive effect of TQ and provides an evidence for the traditional use of Nigella sativa for the
treatment of hypertension. The mechanism of TQ-induced hypotension involves at least in part activation of vascular muscarinic receptors, but not
β-adrenergic receptors. |
---|